Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BAH✓SelectedUSD · BAHGSK vs BAH performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs BAH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
BAH return
+7.7%
Excess return
+35.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioBAHExcessAlpha
1D-2.3%-0.9%-1.5%-2.2%
7D-3.0%-1.2%-1.8%-2.9%
30D+0.4%+16.3%-15.9%-1.2%
3M-1.2%+15.2%-16.4%-2.7%
6M+0.9%+20.6%-19.7%-1.3%
YTD+4.0%+4.7%-0.7%+2.4%
1Y+7.3%+8.2%-0.9%+5.2%
3Y+57.1%-27.8%+84.9%+58.2%
5Y+43.0%+6.9%+36.1%+37.9%
All+43.0%+7.7%+35.2%+37.9%

Cumulative growth

Daily Returns

Daily percentage return beside BAH.

Daily Out/Under-Performance

Portfolio return minus BAH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BAH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded BAH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling